Uncategorized

SPOT/Dx Pilot Publication; Pfeifer JD et al. Reference Samples to Compare Next-Generation Sequencing Test Performance for Oncology Therapeutics and Diagnostics. American Journal of Clinical Pathology 2022

“The data show that 7 (37%) of 19 laboratories correctly reported all variants for both wet and dry samples; [the FDA-approved test] also correctly reported all variants for both wet and dry samples” “Variable accuracy in detection of genetic variants among some...

read more

July 2022 – The Data Driven Point of View Special Edition Interview Newsletter: Justin Zook, Ph.D., Co-Leader, Biomarker & Genetic Sciences Group; National Institute of Standards and Technology (NIST)

Center For Genomic Interpretation (CGI) is very excited to share the interview edition of our monthly newsletter.  Justin Zook, Ph.D. is the Co-Leader of Biomarker and Genomic Sciences Group at the National Institute of Standards and Technology (NIST).  In the...

read more

July 2022 – The Data Driven Point of View Special Edition Interview Newsletter: Justin Zook, Ph.D., Co-Leader, Biomarker & Genetic Sciences Group; National Institute of Standards and Technology (NIST)

Center For Genomic Interpretation (CGI) is very excited to share the interview edition of our monthly newsletter.  Justin Zook, Ph.D. is the Co-Leader of Biomarker and Genomic Sciences Group at the National Institute of Standards and Technology (NIST).  In the...

read more

August 2022 – The Data Driven Point of View

Problem:   What exactly is a physician’s role and responsibility when testing patients for genetic abnormalities?   The American College of Physicians (ACOP) recently released a position paper discussing just this issue. Precision medicine raises many issues...

read more

July 2022 – The Data Driven Point of View Special Edition Interview Newsletter: Justin Zook, Ph.D., Co-Leader, Biomarker & Genetic Sciences Group; National Institute of Standards and Technology (NIST)

Center For Genomic Interpretation (CGI) is very excited to share the interview edition of our monthly newsletter.  Justin Zook, Ph.D. is the Co-Leader of Biomarker and Genomic Sciences Group at the National Institute of Standards and Technology (NIST).  In the...

read more

August 2022 – The Data Driven Point of View

Problem:   What exactly is a physician’s role and responsibility when testing patients for genetic abnormalities?   The American College of Physicians (ACOP) recently released a position paper discussing just this issue. Precision medicine raises many issues...

read more

August 2022 – The Data Driven Point of View

Problem:   What exactly is a physician’s role and responsibility when testing patients for genetic abnormalities?   The American College of Physicians (ACOP) recently released a position paper discussing just this issue. Precision medicine raises many issues...

read more

July 2022 – The Data Driven Point of View Special Edition Interview Newsletter: Justin Zook, Ph.D., Co-Leader, Biomarker & Genetic Sciences Group; National Institute of Standards and Technology (NIST)

Center For Genomic Interpretation (CGI) is very excited to share the interview edition of our monthly newsletter.  Justin Zook, Ph.D. is the Co-Leader of Biomarker and Genomic Sciences Group at the National Institute of Standards and Technology (NIST).  In the...

read more